|
| Status |
Public on Jun 12, 2022 |
| Title |
Dynamic IFNβ signalling underlies treatment response to immune checkpoint therapy in cancer [single-cell RNA-seq] |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
The on/off dynamics of IFNβ signalling underlie the therapeutic response to immune checkpoint therapy in cancer, which can be identified in Ly6C+ monocytes
|
| |
|
| Overall design |
12 samples, 6 across AB1 and 6 across Renca models
|
| |
|
| Contributor(s) |
Zemek R, Lesterhuis WJ |
| Citation(s) |
35986006 |
| BioProject |
PRJNA643595 |
| |
| Submission date |
Jul 07, 2020 |
| Last update date |
Aug 31, 2022 |
| Contact name |
Wee Loong Chin |
| Organization name |
National Centre For Asbestos Related Diseases
|
| Street address |
Level 5, Qq Block, Qeii Medical Centre 6 Verdun St, Nedlands
|
| City |
Perth |
| ZIP/Postal code |
6009 |
| Country |
Australia |
| |
|
| Platforms (1) |
| GPL13112 |
Illumina HiSeq 2000 (Mus musculus) |
|
| Samples (12)
|
|
| This SubSeries is part of SuperSeries: |
| GSE153943 |
Dynamic IFNβ signalling underlies treatment response to immune checkpoint therapy in cancer |
|
| Relations |
| SRA |
SRP271726 |
Less...
More...